238 related articles for article (PubMed ID: 6934544)
1. Cord-blood tyrosine levels in the full-term phenylketonuric fetus and the "justification hypothesis".
Scriver CR; Cole DE; Houghton SA; Levy HL; Grenier A; Laberge C
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6175-8. PubMed ID: 6934544
[TBL] [Abstract][Full Text] [Related]
2. Newborn phenylalanine/tyrosine metabolism. Implications for screening for phenylketonuria.
Schneider AJ
Am J Dis Child; 1983 May; 137(5):427-32. PubMed ID: 6846269
[TBL] [Abstract][Full Text] [Related]
3. Diet, genetics, and mental retardation interaction between phenylketonuric heterozygous mother and fetus to produce nonspecific diminution of IQ: evidence in support of the justification hypothesis.
Bessman SP; Williamson ML; Koch R
Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1562-6. PubMed ID: 274741
[TBL] [Abstract][Full Text] [Related]
4. [Serum tyrosine in children with phenylketonuria and mild hyperphenylalaninemia].
Cabalska B; Nowacka M; Laskowska-Klita T; Nowaczewska I; Zorska K; Taljański W
Med Wieku Rozwoj; 2000; 4(1):5-12. PubMed ID: 11013857
[TBL] [Abstract][Full Text] [Related]
5. HPLC for confirmatory diagnosis and biochemical monitoring of Cuban patients with hyperphenylalaninemias.
Contreras J; Alonso E; Fuentes LE
MEDICC Rev; 2015 Jan; 17(1):23-8. PubMed ID: 25725765
[TBL] [Abstract][Full Text] [Related]
6. Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria.
Luciana M; Sullivan J; Nelson CA
Child Dev; 2001; 72(6):1637-52. PubMed ID: 11768137
[TBL] [Abstract][Full Text] [Related]
7. "Hypotyrosinemia" in phenylketonuria.
Hanley WB; Lee AW; Hanley AJ; Lehotay DC; Austin VJ; Schoonheyt WE; Platt BA; Clarke JT
Mol Genet Metab; 2000 Apr; 69(4):286-94. PubMed ID: 10870846
[TBL] [Abstract][Full Text] [Related]
8. Biochemical effects of induced phenylketonuria in rats.
Poncet IB; Berry HK; Butcher RE; Kazmaier KJ
Biol Neonate; 1975; 26(1-2):88-101. PubMed ID: 125115
[TBL] [Abstract][Full Text] [Related]
9. Can untreated PKU patients escape from intellectual disability? A systematic review.
van Vliet D; van Wegberg AMJ; Ahring K; Bik-Multanowski M; Blau N; Bulut FD; Casas K; Didycz B; Djordjevic M; Federico A; Feillet F; Gizewska M; Gramer G; Hertecant JL; Hollak CEM; Jørgensen JV; Karall D; Landau Y; Leuzzi V; Mathisen P; Moseley K; Mungan NÖ; Nardecchia F; Õunap K; Powell KK; Ramachandran R; Rutsch F; Setoodeh A; Stojiljkovic M; Trefz FK; Usurelu N; Wilson C; van Karnebeek CD; Hanley WB; van Spronsen FJ
Orphanet J Rare Dis; 2018 Aug; 13(1):149. PubMed ID: 30157945
[TBL] [Abstract][Full Text] [Related]
10. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
[TBL] [Abstract][Full Text] [Related]
11. [Embryofetopathy of the newborn infant of a phenylketonuric mother. A diagnosis not to be missed].
Farriaux JP; Dhondt JL; Largillière C; Lacombe A; Valat S; Puech F
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(1):49-52. PubMed ID: 8463567
[TBL] [Abstract][Full Text] [Related]
12. Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours.
Chace DH; Sherwin JE; Hillman SL; Lorey F; Cunningham GC
Clin Chem; 1998 Dec; 44(12):2405-9. PubMed ID: 9836704
[TBL] [Abstract][Full Text] [Related]
13. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
[TBL] [Abstract][Full Text] [Related]
14. Altered tetrahydrobiopterin metabolism in patients with phenylalanine hydroxylase deficiency.
Nardecchia F; Chiarotti F; Carducci C; Santagata S; Valentini G; Angeloni A; Blau N; Leuzzi V
Eur J Pediatr; 2017 Jul; 176(7):917-924. PubMed ID: 28540433
[TBL] [Abstract][Full Text] [Related]
15. Phenylalanine tolerance in three phenylketonuric women pregnant with fetuses of different genetic PKU status.
Kohlschütter B; Ellerbrok M; Merkel M; Tchirikov M; Zschocke J; Santer R; Ullrich K
J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S1-4. PubMed ID: 19194782
[TBL] [Abstract][Full Text] [Related]
16. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
Diamond A; Prevor MB; Callender G; Druin DP
Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
[TBL] [Abstract][Full Text] [Related]
17. Phenylketonuria: screening, treatment and maternal PKU.
Matalon R; Michals K
Clin Biochem; 1991 Aug; 24(4):337-42. PubMed ID: 1959225
[TBL] [Abstract][Full Text] [Related]
18. Determination of Phenylalanine and Tyrosine by High Performance Liquid Chromatography-Tandem Mass Spectrometry.
Peat J; Garg U
Methods Mol Biol; 2016; 1378():219-25. PubMed ID: 26602133
[TBL] [Abstract][Full Text] [Related]
19. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
Boot E; Hollak CEM; Huijbregts SCJ; Jahja R; van Vliet D; Nederveen AJ; Nieman DH; Bosch AM; Bour LJ; Bakermans AJ; Abeling NGGM; Bassett AS; van Amelsvoort TAMJ; van Spronsen FJ; Booij J
Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous measurement of phenylalanine and tyrosine in phenylketonuric plasma and dried blood by high-performance liquid chromatography.
Dale Y; Mackey V; Mushi R; Nyanda A; Maleque M; Ike J
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(1):1-8. PubMed ID: 12668065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
